Melanotan 2 interacts with more receptors and may cause broader effects such as nausea, reduced appetite and changes in sexual function
That distinction has become increasingly important as insurers and employers scrutinize the long-term economics of GLP-1 therapies, which can carry annual costs exceeding $10,000 per patient while generating uncertainty around sustained adherence rates and long-term reimbursement models
Mild to moderate nausea is uncomfortable but not dangerous for most patients
These effects collectively contribute to increased seizure thresholds and improved depressive symptoms (Shou and Shaw, 2022)
Microglia-specific overexpression of -synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity
Medications like Ozempic, Wegovy, and Mounjaro have significantly changed the landscape of treating type 2 diabetes and obesity